open access

Vol 11, No 3 (2016)
Case Reports
Published online: 2016-07-13
Get Citation

Challenging choices in patients with both high thromboembolic and bleeding risk - clinical case of 81-year old woman with high risk of stroke after gastrointestinal bleeding event

Maciej Krzysztof Kluk, Kamilla Wesołowska, Agnieszka Woronowicz-Chróściel, Beata Wożakowska-Kapłon
DOI: 10.5603/FC.2016.0037
·
Folia Cardiologica 2016;11(3):228-232.

open access

Vol 11, No 3 (2016)
Case Reports
Published online: 2016-07-13

Abstract

The problem of serious bleeding complications, like gastrointestinal bleeding, generates the main risk associated with chronic anticoagulation, including non vitamin K oral anticoagulants (NOAC), in patients with atrial fibrillation. A presented case report of 81-year old woman demonstrates that recovering from the life-threatening gastrointestinal bleeding is not a contraindication to restart NOAC therapy, especially when the thromboembolic risk is high. NOAC give an opportunity to choose the optimal treatment considering age, renal function as well as CHA2DS2VASc and HAS-BLED scores. Apixaban is suggested to be favoured in patients with high risk of gastrointestinal bleeding recurrence and serious renal function impairment.

Abstract

The problem of serious bleeding complications, like gastrointestinal bleeding, generates the main risk associated with chronic anticoagulation, including non vitamin K oral anticoagulants (NOAC), in patients with atrial fibrillation. A presented case report of 81-year old woman demonstrates that recovering from the life-threatening gastrointestinal bleeding is not a contraindication to restart NOAC therapy, especially when the thromboembolic risk is high. NOAC give an opportunity to choose the optimal treatment considering age, renal function as well as CHA2DS2VASc and HAS-BLED scores. Apixaban is suggested to be favoured in patients with high risk of gastrointestinal bleeding recurrence and serious renal function impairment.

Get Citation

Keywords

non vitamin K oral anticoagulants, thromboembolic risk, bleeding risk, gastrointestinal bleeding, dabigatran, apixaban

About this article
Title

Challenging choices in patients with both high thromboembolic and bleeding risk - clinical case of 81-year old woman with high risk of stroke after gastrointestinal bleeding event

Journal

Folia Cardiologica

Issue

Vol 11, No 3 (2016)

Pages

228-232

Published online

2016-07-13

DOI

10.5603/FC.2016.0037

Bibliographic record

Folia Cardiologica 2016;11(3):228-232.

Keywords

non vitamin K oral anticoagulants
thromboembolic risk
bleeding risk
gastrointestinal bleeding
dabigatran
apixaban

Authors

Maciej Krzysztof Kluk
Kamilla Wesołowska
Agnieszka Woronowicz-Chróściel
Beata Wożakowska-Kapłon

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

 

Wydawcą serwisu jest  "Via Medica sp. z o.o." sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail:  viamedica@viamedica.pl